SCHEMBL16797634

SCHEMBL16797634

CCOC(=O)C(CO)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.53
LMNA P02545 1/20 0.53
MAOB P27338 2/20 0.51
ALOX5 P09917 1/20 0.51
NR4A2 P43354 1/20 0.50
MEN1 O00255 1/20 0.48
CYP4F2 P78329 1/20 0.48
CYP4A11 Q02928 1/20 0.48
PRKCA P17252 2/20 0.47
PRKCD Q05655 2/20 0.47
LTB4R Q15722 1/20 0.46
LTB4R2 Q9NPC1 1/20 0.46
TSHR P16473 2/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
SMPD1 P17405 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485036 0.84 KMT2A (0.56) KMT2ASMN1; SMN2L3MBTL1LMNAMAOB
SCHEMBL2381049 0.82 KMT2A (0.60) KMT2ASMN1; SMN2MAOBALOX5NR4A2
SCHEMBL6366231 0.81 L3MBTL1 (0.52) L3MBTL1TSHRMAPK1TDP1
SCHEMBL6366230 0.81 L3MBTL1 (0.52) L3MBTL1TSHRMAPK1TDP1
SCHEMBL15232861 0.81 KMT2A (0.59) KMT2ASMN1; SMN2MAOBALOX5NR4A2
SCHEMBL5379536 0.81 KMT2A (0.53) KMT2ASMN1; SMN2L3MBTL1LMNAMAOB
SCHEMBL4951331 0.81 KMT2A (0.53) KMT2ASMN1; SMN2L3MBTL1LMNAMAOB
SCHEMBL6366936 0.80 HPGD (0.55) KMT2ASMN1; SMN2MEN1
SCHEMBL5811954 0.79 MMP8 (0.54) KMT2ALMNAMEN1
SCHEMBL10635430 0.79 MMP8 (0.54) KMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10081615-B2 Sulfamate derivative compounds for use in treating or alleviating pain BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-09-25 US disclosed
EP-3079687-B1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN BIO-PHARM SOLUTIONS CO LTD (KR) 2018-02-28 EP disclosed
US-20160311792-A1 Sulfamate Derivative Compounds for Use in Treating or Alleviating Pain BIO-PHARM SOLUTIONS CO., LTD. (KR) 2016-10-27 US disclosed
EP-3079687-A1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN Bio-Pharm Solutions Co., Ltd. (KR) 2016-10-19 EP disclosed
WO-2015088272-A9 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN BIO-PHARM SOLUTIONS CO., LTD. (KR) 2015-10-01 WO disclosed
WO-2015088272-A1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN BIO-PHARM SOLUTIONS CO., LTD. (KR) 2015-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311792-A1 Sulfamate Derivative Compounds for Use in Treating or Alleviating Pain SULT2A1, SULT1A1, TRPV1 KMT2A 1146/4885SMN1; SMN2 465/4885L3MBTL1 4778/4885
US-10081615-B2 Sulfamate derivative compounds for use in treating or alleviating pain SULT2A1, SULT1A1, TRPV1 KMT2A 1146/4885SMN1; SMN2 465/4885L3MBTL1 4778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.